... Occupationally-related COPD: management and prevention Directions about the management and prevention of work-related diseases [33-35], can be applied to COPD as well Physicians should attempt to understand the ... airway disease Am J Respir Crit Care Med 2003, 167:787-797 Hnizdo E, Sullivan PA, Bang KM, Wagner G: Association between chronicobstructivepulmonarydiseaseand employment by industry and occupation ... human pulmonary emphysema Lab Invest 1998, 78:1077-1087 Petty TL, Weinmann GG: Building a national strategy for the prevention and management of and research in chronicobstructivepulmonary disease...
... with chronicobstructivepulmonarydisease Am J Psychiatry 1990, 147:200-201 Zandbergen J, Bright M, Pols H, Fernandez I, de Loof C, Griez EJ: Higher lifetime prevalence of respiratorydiseases ... with chronicobstructivepulmonary disease: a review J Psychosom Res 2005, 59:429-443 25 Feiguine RJ, Johnson FA: Alexithymia andchronicrespiratorydisease A review of current research Psychother ... comparative study of anxiety and depression in patients with bronchial asthma, chronicobstructivepulmonarydiseaseand tuberculosis in a general hospital of chest diseases Ann Gen Psychiatry...
... role of mediators and effects of new aerosolized compounds on airway secretion in the background of COPD 10 11 12 13 14 15 16 17 18 19 Barnes PJ: Chronicobstructivepulmonarydisease N Engl J ... Medicine and Toxicology 2006, 1:12 http://www.occup-med.com/content/1/1/12 Figure Proliferative activity of glandular and surface epithelial cells Proliferative activity of glandular and surface ... other I.e an index of 1.8 ± 0.1 was found for control animals and 3.9 ± 0.3 (p < 0.05) For ductal epithelial cells, significant differences were only found between control and 10 ppm and 10 and...
... to HSV and its role in difficult to treat exacerbations of COPD may be underestimated Diagnosis may be considered in patients with chronic lung disease, especially during exacerbations of COPD ... pathogen in the lungs of patients with severe respiratory distress Scandinavian Journal of Infectious Diseases 1992, 24(3):283-92 Publish with Bio Med Central and every scientist can read your work ... Case review, literature review and drafting the manuscript LHI: Literature review and editing manuscript MWE: Manuscript critique and review All authors have read and approved the final manuscript...
... MC, Plaza V, Prieto L, Anto JM: Chronicobstructivepulmonarydisease stage and health-related quality of life The Quality of Life of ChronicObstructivePulmonaryDisease Study Group Ann Intern ... wasting among patients with chronicobstructivepulmonarydisease Clin Nutr 1999, 18:275-280 Schols AM: Nutritional and metabolic modulation in chronicobstructivepulmonarydisease management Eur ... with chronicobstructivepulmonary disease, asthma, andchronic arthritis Am J Respir Crit Care Med 2000, 161:32-35 Oudijk EJ, Lammers JW, Koenderman L: Systemic inflammation in chronic obstructive...
... subjects with asthma symptoms, but the association with otherrespiratory end- Table Dietary factors and asthma or chronicobstructivepulmonary disease: summary of the available evidence Relatively ... Smit HA, Heederik D, Ocké MC, Kromhout D: Diet andchronicobstructivepulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study) Clin Exp Allergy ... the interpretation of the observed protective effect of diet on respiratorydisease Smoking has great impact on respiratory disease, and dietary habits of smokers are less favourable than those...
... pollution and change in prevalence in respiratory symptoms andchronicobstructivepulmonarydisease in elderly women Respiratory Research 2010 11:113 Submit your next manuscript to BioMed Central and ... and manifestations of obstructive lung disease in the city of Oslo Scand J Respir Dis 1979, 60(5):286-296 Lindstrom M, Kotaniemi J, Jonsson E, Lundback B: Smoking, respiratory symptoms, and diseases: ... prevention of chronicobstructivepulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for ChronicObstructive Lung Disease (GOLD): executive...
... burden and impact of chronicobstructivepulmonarydisease worldwide Monaldi Archives for Chest Disease 2001; 56: 261-264 Anto JM, Vermeire P, Vestbo J, Sunyer J Epidemiology of chronicobstructive ... Int J Med Sci 2007, disease [5] How we account for these increases in rates of COPD? Chronicobstructivepulmonarydisease (COPD) is a condition characterized by progressive ... of relationships between COPD charges andother socio-demographic factors We are thus limited in our ability to determine etiological relationships between COPDandother measures We not have...
... activity in chronicobstructivepulmonarydisease N Engl J Med exercise intolerance in chronicobstructivepulmonarydisease Am J Respir Crit Care Med L- chronicobstructivepulmonarydisease Eur ... obstruction in chronicobstructivepulmonarydisease N Engl J Med parenchyma in COPD: role of T cells Chest HT E Wright JL, Levy RD, Churg A Pulmonary hypertension in chronicobstructivepulmonary disease: ... effects in COPD Chest MA T X Systemic effects of chronicobstructivepulmonarydisease Eur Respir J potential impact of anaemia of chronicdisease in COPD Eur Respir J HT E D between chronic obstructive...
... admissions for chronicobstructivepulmonarydisease Am J Epidemiol 1991; 134: 277– 86 54 Arbex MA, Conceicao GM, Cendon SP et al Urban air pollution andchronicobstructivepulmonary disease- related ... symptoms andchronicobstructivepulmonarydisease in elderly women Respir Res 2010; 11: 113 17 Pujades-Rodriguez M, McKeever T, Lewis S et al Effect of traffic pollution on respiratoryand allergic disease ... disease in adults: crosssectional and longitudinal analyses BMC Pulm Med 2009; 9: 42 18 Andersen ZJ, Hvidberg M, Jensen SS et al Chronicobstructivepulmonarydiseaseand long-term exposure to traffic-related...
... 1.3 ChronicobstructivepulmonarydiseaseChronicobstructivepulmonarydisease (COPD) is characterized by progressive airflow obstruction which is irreversible COPD is a complex of two chronic ... Introduction The chronicobstructivepulmonarydisease (COPD) encompasses two phenotypically related diseases, chronic bronchitis and emphysema [1-2] Although the hallmark of COPD is inflammation and inability ... Specialist - Respiratory Medicine, Mt Elizabeth Medical Centre Global Initiative for ChronicObstructive Lung Disease (GOLD) National Leader President, ChronicObstructivePulmonaryDisease Association...
... anxiety and depression in chronic breathing disorders Chest 2005, 127(4):1205-1211 Society AT, Society ER: Standards for the diagnosis and treatment of patients with chronicobstructivepulmonarydisease ... Coventry PA, Hind D: Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronicobstructivepulmonary disease: Systematic review and meta-analysis Journal of psychosomatic ... respiratorydisease questionnaire (CRQ) Copd 2005, 2(1):81-89 Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, Goldstein RS: Pulmonary rehabilitation for chronicobstructivepulmonary disease...
... Rehabilitation andCOPD Seminars in respiratoryand criticare Medicine 2005, 26:133-141 Pauwels RA, Rabe KF: Burden and clinical features of chronicobstructivepulmonarydisease (COPD) Lancet ... Aguirre-Jaime A, Celli BR: Gender andCOPD in patients attending a pulmonary clinic Chest 2005, 128:2012-2016 Anderson KL: The effect of chronicobstructivepulmonarydisease on quality of life Res ... for the diagnosis, management and prevention of chronicobstructivepulmonarydisease GOLD Science Committee Oregon, Global initiative for chronicObstructive Lung Disease; 2007:1-89 Hoogendoorn...
... the relationship between chronic pain and depression [14] Chronicrespiratorydiseases such as COPDand BA entail serious subjective difficulties, chronic psychogenic and somatic pain, frequent ... with the higher and more severe depression comorbidity Depression in patients with chronicrespiratorydiseases coexists with anxiety and is related to the chronicity of the disease in our study, ... personnel The observed higher prevalence of depression and anxiety in patients with chronicpulmonarydisease – compared to otherchronicdiseases – may be explained within this context Despite...
... 120%, bilateral trans-tibial amputation 60-100% and bilateral transfemoral amputation > 200% Patients with severe chronicobstructivepulmonarydisease (COPD) are rarely offered limb prostheses as ... lower-limb prosthesis and successfully rehabilitated In our opinion, patients with severe COPD should be carefully assessed, regardless of their age and preexisting respiratory disorders, and a trial period ... temporo-spatial parameters of gait in young and older people Gait Posture 2004, 20:20-25 11 Sioson ER: The elderly amputee with severe chronicobstructivepulmonary disease: case reports J Am Geriatr...
... between disease markers and health status (HS) overtime is unclear The aim of this study was to verify the predictors of HS at baseline and after three years in ChronicObstructivePulmonaryDisease ... BODE index, dyspnea Introduction Chronicobstructivepulmonarydisease (COPD) has significant extrapulmonary consequences that lead to comorbidity conditions and effects on patients’ quality ... investigators: Salmeterol and fluticasone propionate and survival in chronicobstructivepulmonarydisease N Engl J Med 2007, 356: 775–789 36 Fayers PM, Sprangers MAG: Understanding self rated health...
... remodelling in chronic airway diseases? Pharmacology & Therapeutics 2008, 118:128-137 GOLD GIfCOLD: Global strategy for the Diagnosis, Mangement and Prevention of ChronicObstructivePulmonaryDisease ... was fragmented and had markedly increased splitting in smokers andCOPD (Figures and 2), and especially in current smoking COPD The Rbm was hypervascular in smokers but not in ES -COPD The LP was ... abbreviations BB: bronchial biopsies; COPD: chronicobstructivepulmonary disease; DLCO: diffusion of carbon monoxide in the lung; ES -COPD: Ex-smokers with COPD; FEV1: Forced expiratory volume...
... (98.5%) COPD: chronicobstructivepulmonarydisease Figure Patient disposition in a) ACCLAIM /COPD I, and b) ACCLAIM /COPD II ACCLAIM /COPD I (by 61 and 67 mL, respectively; both p < 0.001) and ACCLAIM /COPD ... ACCLAIM/ COPD I COPD II 0.2 20 Aclidinium 200 μg Placebo 0.1 0.0 ACCLAIM/ COPD I ACCLAIM/ COPD II Week 12 ACCLAIM/ COPD I ACCLAIM/ COPD II Week 28 ACCLAIM/ COPD I ACCLAIM/ COPD II Week 44 ACCLAIM/ COPD ... slightly greater in Peak IC, mL ACCLAIM/ COPD I ACCLAIM/ COPD II ACCLAIM/ COPD I ACCLAIM/ COPD II ACCLAIM/ COPD I ACCLAIM/ COPD II ACCLAIM/ COPD I ACCLAIM/ COPD II 147-177 ‡ 166-204 171-220‡ Week...